NEW YORK (GenomeWeb News) - Waters said today that XenoTech, a contract research organization based in Lenexa, Kan., has purchased a Waters Synapt High Definition Mass Spectrometry system.
XenoTech is using the system to provide metabolite profiling services, Waters said.
The CRO is using the Synapt, in combination with a Waters Acquity UltraPerformance Liquid Chromatograph, to provide its clients with in vitro drug metabolism study data.
Waters said that XenoTech purchased the Synapt system after an "exhaustive six-month evaluation of the offerings of all commercial instrument providers."
Financial terms of the agreement were not provided.